Document_And_Entity_Informatio
Document And Entity Information (USD $) | 12 Months Ended | ||
Dec. 31, 2014 | Mar. 31, 2015 | Jun. 30, 2014 | |
Document Information [Line Items] | |||
Entity Registrant Name | SIGMA LABS, INC. | ||
Entity Central Index Key | 788611 | ||
Current Fiscal Year End Date | -19 | ||
Entity Filer Category | Smaller Reporting Company | ||
Trading Symbol | SGLB | ||
Entity Common Stock, Shares Outstanding | 623,344,835 | ||
Document Type | 10-K | ||
Amendment Flag | FALSE | ||
Document Period End Date | 31-Dec-14 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2014 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Public Float | $64,931,219.39 |
Consolidated_Balance_Sheets
Consolidated Balance Sheets (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
Current Assets | ||
Cash | $2,962,069 | $992,448 |
Accounts Receivable, net | 117,726 | 303,445 |
Inventory | 56,175 | 1,167 |
Prepaid Assets | 29,986 | 25,074 |
Total Current Assets | 3,165,956 | 1,322,134 |
Other Assets | ||
Property and Equipment, net | 803,027 | 11,419 |
Deferred Stock Offering Costs | 95,511 | 17,426 |
Intangible Assets, net | 95,847 | 70,494 |
Total Other Assets | 994,385 | 99,339 |
TOTAL ASSETS | 4,160,341 | 1,421,473 |
Current Liabilities | ||
Accounts Payable | 309,698 | 102,625 |
Accrued Expenses | 44,652 | 38,536 |
Total Current Liabilities | 354,350 | 141,161 |
TOTAL LIABILITIES | 354,350 | 141,161 |
Stockholders' Equity | ||
Preferred Stock, $0.001 par; 10,000,000 shares authorized; None issued and outstanding | 0 | 0 |
Common Stock, $0.001 par; 750,000,000 shares authorized;619,741,061 issued and 612,741,061 outstanding at December 31, 2014 and 559,766,061 issued and 556,816,061 outstanding at December 31, 2013 and | 619,741 | 559,766 |
Additional Paid-In Capital | 9,798,288 | 3,561,204 |
Less Deferred Compensation 7,000,000 and 2,950,000 common shares, respectively | -744,200 | -88,900 |
Retained Earnings (Deficit) | -5,867,838 | -2,751,758 |
Total Stockholders' Equity | 3,805,991 | 1,280,312 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $4,160,341 | $1,421,473 |
Consolidated_Balance_Sheets_Pa
Consolidated Balance Sheets [Parenthetical] (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
Preferred stock, par value (in dollars per share) | $0.00 | $0.00 |
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value (in dollars per share) | $0.00 | $0.00 |
Common stock, shares authorized | 750,000,000 | 750,000,000 |
Common stock, share issued | 619,741,061 | 559,766,061 |
Common stock, shares outstanding | 612,741,061 | 556,816,061 |
Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance | 7,000,000 | 2,950,000 |
Consolidated_Statement_of_Oper
Consolidated Statement of Operations (USD $) | 12 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
INCOME | ||
Services | $548,723 | $1,071,439 |
Total Revenue | 548,723 | 1,071,439 |
COST OF SERVICE REVENUE | 158,936 | 488,627 |
GROSS PROFIT | 389,787 | 582,812 |
EXPENSES | ||
Other general and Administration | 1,020,262 | 709,948 |
Payroll Expense | 404,054 | 247,619 |
Non-cash Stock Compensation | 582,550 | 258,400 |
Warrant Expense | 1,283,333 | 0 |
Research and development | 219,132 | 14,275 |
Impairment of Intangible Assets | 0 | 87,340 |
Total Expenses | 3,509,331 | 1,317,582 |
OTHER INCOME (EXPENSE) | ||
Interest Income | 3,464 | 653 |
Interest Expense | 0 | 0 |
Total Other Income (Expense) | 3,464 | 653 |
INCOME (LOSS) BEFORE INCOME TAXES | -3,116,080 | -734,117 |
Current Income Tax Expense | 0 | 0 |
Deferred Income Tax Expense | 0 | 0 |
Net Income (Loss) | ($3,116,080) | ($734,117) |
Loss per Common Share - Basic and Diluted (in dollars per share) | ($0.01) | $0 |
Weighted Average Number of Shares Outstanding - Basic and Diluted (in shares) | 610,344,691 | 489,921,337 |
Statement_of_Stockholders_Equi
Statement of Stockholders' Equity (USD $) | Total | Common Stock [Member] | Additional Paid-in Capital [Member] | Deferred Compensation [Member] | Retained Earnings [Member] |
Balance at Dec. 31, 2012 | $557,770 | $429,167 | $2,226,244 | ($80,000) | ($2,017,641) |
Balance (in Shares) at Dec. 31, 2012 | 429,167,400 | ||||
Unvested shares cancelled | -82,500 | -3,250 | -89,250 | 10,000 | 0 |
Unvested shares cancelled (in Shares) | -3,250,000 | ||||
Shares vested | 35,000 | 0 | 0 | 35,000 | 0 |
Shares issued | 1,505,900 | 133,849 | 1,425,951 | -53,900 | 0 |
Shares issued (in Shares) | 133,848,661 | ||||
Costs incurred in association with shares issued | -30,054 | 0 | -30,054 | 0 | 0 |
Contributions made during the period | 28,313 | 0 | 28,313 | 0 | 0 |
Contributions made during the period (in Shares) | 0 | ||||
Net loss | -734,117 | 0 | 0 | 0 | -734,117 |
Balance at Dec. 31, 2013 | 1,280,312 | 559,766 | 3,561,204 | -88,900 | -2,751,758 |
Balance (in Shares) at Dec. 31, 2013 | 559,766,061 | ||||
Shares vested | 88,250 | 0 | 0 | 88,250 | 0 |
Shares issued for services at prices ranging from $0.094 to $0.136 | 494,300 | 9,975 | 1,227,875 | -743,550 | 0 |
Shares issued for services at prices ranging from $0.094 to $0.136 (in Shares) | 9,975,000 | ||||
Shares issued for cash at a price of $0.08 per share | 4,000,000 | 50,000 | 3,950,000 | 0 | 0 |
Shares issued for cash at a price of $0.08 per share (in Shares) | 50,000,000 | ||||
Costs incurred in association with shares issued | -224,124 | 0 | -224,124 | 0 | 0 |
Costs incurred in association with warrant issuances | 1,283,333 | 0 | 1,283,333 | 0 | 0 |
Net loss | -3,116,080 | 0 | 0 | 0 | -3,116,081 |
Balance at Dec. 31, 2014 | $3,805,991 | $619,741 | $9,798,288 | ($744,200) | ($5,867,839) |
Balance (in Shares) at Dec. 31, 2014 | 619,741,061 |
Statement_of_Stockholders_Equi1
Statement of Stockholders' Equity [Parenthetical] (USD $) | 12 Months Ended |
Dec. 31, 2014 | |
Shares issued for cash (in dollars per share) | $0.08 |
Maximum [Member] | |
Shares issued for services (in dollars per share) | $0.14 |
Minimum [Member] | |
Shares issued for services (in dollars per share) | $0.09 |
Consolidated_Statements_of_Cas
Consolidated Statements of Cash Flows (USD $) | 12 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
OPERATING ACTIVITIES | ||
Net Income (Loss) | ($3,116,080) | ($734,117) |
Noncash Expenses: | ||
Impairment of Intangible Assets | 0 | 87,340 |
Amortization | 2,309 | 89,513 |
Depreciation | 20,340 | 10,587 |
Stock Compensation | 582,550 | 258,400 |
Warrant Expense | 1,283,333 | 0 |
Change in assets and liabilities: | ||
Decrease (Increase) in Accounts Receivable | 185,719 | -30,163 |
(Increase) in Inventory | -55,008 | -1,167 |
(Increase) in Prepaid Assets | -4,912 | 1,089 |
Increase (Decrease) in Accounts Payable | 207,073 | -3,970 |
Increase In Accrued Expenses | 6,116 | 11,189 |
NET CASH PROVIDED (USED) BY OPERATING ACTIVITIES | -888,560 | -311,299 |
INVESTING ACTIVITIES | ||
Purchase of Furniture and Equipment | -811,948 | -11,613 |
Purchase of Intangible Assets | -27,662 | -15,544 |
NET CASH (USED) BY INVESTING ACTIVITIES | -839,610 | -27,157 |
FINANCING ACTIVITIES | ||
Proceeds from Sale of Stock Subscriptions | 4,000,000 | 1,169,946 |
Stock Offering Costs | -206,698 | |
Deferred Stock Offering Costs | -95,511 | -17,426 |
Contributions | 0 | 28,313 |
NET CASH PROVIDED BY FINANCING ACTIVITIES | 3,697,791 | 1,180,833 |
NET CASH INCREASE (DECREASE) FOR PERIOD | 1,969,621 | 842,377 |
CASH AT BEGINNING OF PERIOD | 992,448 | 150,071 |
CASH AT END OF PERIOD | 2,962,069 | 992,448 |
Supplemental Disclosure for Cash Flow Information | ||
Interest | 0 | 0 |
Income Taxes | $0 | $0 |
Supplemental_Schedule_of_Nonca
Supplemental Schedule of Noncash Investing and Financing Activities (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2014 | |
Class Of Warrant Or Right, Number Of Securities Called By Warrants Or Rights | 5,098,661 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares | 500,000 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested | $10,000 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value | $0.02 | |
Director [Member] | ||
Stock Issued During Period, Shares, Issued for Services | 1,500,000 | |
Shares Issued, Price Per Share | $0.16 | $0.09 |
Employee [Member] | ||
Stock Issued During Period, Shares, Issued for Services | 6,000,000 | |
Shares Issued, Price Per Share | $0.13 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | 1,500,000 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | 4,500,000 | |
Two Employees and One Director [Member] | ||
Stock Issued During Period, Shares, Issued for Services | 850,000 | |
Shares Issued, Price Per Share | $0.14 | |
Equity Incentive Plan [Member] | ||
Shares Issued, Price Per Share | $0.07 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | 1,950,000 | |
Increase (Decrease) in Deferred Compensation | 66,200 | |
Stock Issued During Period, Shares, New Issues | 1,000,000 | |
Equity Incentive Plan Two [Member] | ||
Increase (Decrease) in Deferred Compensation | $35,000 | |
Stock Issued During Period, Shares, New Issues | 1,750,000 | |
Consultant One [Member] | ||
Stock Issued During Period, Shares, Issued for Services | 500,000 | 375,000 |
Shares Issued, Price Per Share | $0.06 | $0.13 |
Consultant Two [Member] | ||
Stock Issued During Period, Shares, Issued for Services | 4,250,000 | |
Shares Issued, Price Per Share | $0.03 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | 1,500,000 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | 2,750,000 | |
Consultant Three [Member] | ||
Stock Issued During Period, Shares, Issued for Services | 2,000,000 | 1,250,000 |
Shares Issued, Price Per Share | $0.02 | $0.13 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | 1,000,000 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | 1,000,000 | |
Consultant Four [Member] | ||
Stock Issued During Period, Shares, Issued for Services | 500,000 | |
Shares Issued, Price Per Share | $0.02 | |
Consultant Five [Member] | ||
Stock Issued During Period, Shares, Issued for Services | 500,000 | |
Shares Issued, Price Per Share | $0.16 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | 300,000 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | 200,000 | |
Warrant One [Member] | ||
Stock Issued During Period, Shares, New Issues | 14,259,259 | |
Warrant Two [Member] | Consultant Two [Member] | ||
Stock Issued During Period, Shares, New Issues | 2,187,500 | |
Warrant Three [Member] | ||
Stock Issued During Period, Shares, New Issues | 2,037,037 | |
Warrant Four [Member] | Consultant Four [Member] | ||
Stock Issued During Period, Shares, Issued for Services | 312,500 |
Summary_of_Significant_Account
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2014 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies [Text Block] | NOTE 1 – Summary of Significant Accounting Policies |
Nature of Business – On September 13, 2010 Sigma Labs, Inc., formerly named Framewaves, Inc., a Nevada corporation (the “Company”), acquired 100% of the shares of B6 Sigma, Inc. by exchanging 6.67 shares of Framewaves, Inc. restricted common stock for each issued and outstanding share of B6 Sigma, Inc. The acquisition has been accounted for as a “reverse purchase”, and accordingly the operations of Framewaves, Inc. prior to the date of acquisition have been eliminated. | |
B6 Sigma, Inc., incorporated February 5, 2010, was founded by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials technologies. Management believes that some of these technologies will fundamentally redefine conventional quality assurance and control practices by embedding quality assurance and process control into the manufacturing processes in real time. The Company anticipates that its core technologies will allow its clientele to combine advanced manufacturing quality assurance and control protocols with novel materials to achieve breakthrough product potential in many industries including aerospace, defense, oil and gas, prosthetic implants, and power generation. | |
As of December 31, 2011, Sigma Labs, Inc. acquired 100% of the shares of Sumner & Lawrence Limited (“Sumner”), a New Mexico Corporation, and La Mancha Company, a New Mexico Corporation, in exchange for 35,000,000 shares of Sigma Labs, Inc. common stock. The operations of Sumner and La Mancha Company prior to the date of acquisition have been eliminated. La Mancha Company and Sumner have since ceased all operations and were dissolved in 2013 and 2014, respectively. | |
Basis of Presentation – The accompanying consolidated financial statements have been prepared by the Company in accordance with Article 8 of U.S. Securities and Exchange Commission Regulation S-X. | |
Reclassification – Certain amounts in prior-period financial statements have been reclassified for comparative purposes to conform to presentation in the current-period financial statements. | |
Principles of Consolidation – The consolidated financial statements for December 31, 2014 include the accounts of Sigma Labs, Inc., B6 Sigma, Inc. and Sumner & Lawrence Limited. All significant intercompany balances and transactions have been eliminated. | |
Property and Equipment – Property and equipment are stated at cost. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized upon being placed in service. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated life has been determined to be three years unless a unique circumstance exists, which is then fully documented as an exception to the policy. | |
Fair Value of Financial Instruments – The Company estimates that the fair value of all financial instruments does not differ materially from the aggregate carrying values of its financial instruments recorded in the accompanying consolidated balance sheets because of the short-term maturity of these financial instruments. | |
Income Taxes – The Company accounts for income taxes in accordance with ASC Topic No. 740, “Accounting for Income Taxes.” | |
The Company adopted the provisions of ASC Topic No. 740, “Accounting for Income Taxes,” at the date of inception on February 5, 2010. As a result of the implementation of ASC Topic No. 740, the Company recognized no increase in the liability for unrecognized tax benefits. | |
The Company has no tax positions at December 31, 2014 and 2013 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. | |
The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the year ended December 31, 2014, the Company recognized no interest and penalties. The Company had no accruals for interest and penalties at December 31, 2014 or 2013. All tax years starting with 2010 are open for examination. | |
Loss Per Share – The computation of loss per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, “Earnings Per Share.” | |
Accounts Receivable and Allowance for Doubtful Accounts - Trade accounts receivable are carried at original invoice amount less an estimate made for doubtful accounts. We determine the allowance for doubtful accounts by identifying potential troubled accounts and by using historical experience and future expectations applied to an aging of accounts. Trade accounts receivable are written off when deemed uncollectible. Recoveries of trade accounts receivable previously written off are recorded as income when received. The allowance for doubtful accounts at December 31, 2014 and 2013 was $4,884 and $4,884 respectively. | |
Long-Lived and Intangible Assets – Long-lived assets and certain identifiable definite life intangibles to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously evaluates the recoverability of its long-lived assets based on estimated future cash flows and the estimated liquidation value of such long-lived assets, and provides for impairment if such undiscounted cash flows are insufficient to recover the carrying amount of the long-lived assets. If impairment exists, an adjustment is made to write the asset down to its fair value, and a loss is recorded as the difference between the carrying value and fair value. Fair values are determined based on quoted market values, discounted cash flows or internal and external appraisals, as applicable. Assets to be disposed of are carried at the lower of carrying value or estimated net realizable value. No impairment was recorded in the year ended December 31, 2014. During the year ended December 31, 2013, an impairment of $87,340 was recorded to reduce the value of customer contacts intangible assets of Sumner as management had planned to discontinue servicing the related contracts in 2014. | |
Recently Enacted Accounting Standards – The FASB established the Accounting Standards Codification (“Codification” or “ASC”) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States (“GAAP”). Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) issued under authority of federal securities laws are also sources of GAAP for SEC registrants. | |
Recent Accounting Standards Updates (“ASU”) through ASU No. 2014-16 contain technical corrections to existing guidance or affects guidance to specialized industries. These updates have no current applicability to the Company or their effect on the financial statements would not have been significant. | |
Cash Equivalents - The Company considers all highly liquid investments with an original maturity of three months or less at date of purchase to be cash equivalents. | |
Concentration of Credit Risk - The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents. | |
Organization Expenditures – Organizational expenditures are expensed as incurred for SEC filings, but capitalized and amortized for income tax purposes. | |
Stock Based Compensation – The Company recognizes compensation costs to employees under ASC Topic No. 718, “Compensation – Stock Compensation.” Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with and without restrictions, performance based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option or stock grants. Unvested option or stock grant for compensation are included in the Statement of Shareholders Equity as a contra-equity account as “Deferred Compensation”. | |
Equity instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 505, “Equity Based Payments to Non-Employees.” In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that (i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards Codification. | |
Amortization - Utility patents are amortized over a 17 year period. Patents which are pending are not amortized. The customer contacts intangible asset was being amortized over a 3 year period. | |
Accounting Estimates - The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowances for bad debts and inventory obsolescence. | |
Revenue Recognition – The Company’s revenue is derived primarily from providing services under contracts. The Company recognizes revenue in accordance with ASC Topic No. 605 based on the following criteria: Persuasive evidence of an arrangement exists, services have been rendered, the price is fixed or determinable, and collectability is reasonably assured. In general, the Company recognizes service revenue as significant services under the relevant arrangement have been performed. | |
Deferred Stock Offering Costs – Costs related to proposed stock offerings if any are deferred and will be offset against the proceeds of the offering in additional paid-in capital. In the event a stock offering is unsuccessful, the costs relating to the offering will be written-off directly to expense. | |
Inventory – Inventories consist of raw materials used in the production of customized parts totaling $11,242 and work in process components totaling $44,933 which will be sold to customers. Inventories are valued at the lower of cost or market. | |
Research and Development – Research and development costs are expensed as they are incurred. Research and development costs for the years ended December 31, 2014 and 2013 were $219,132 and $14,275, respectively. | |
Stockholders_Equity
Stockholders' Equity | 12 Months Ended |
Dec. 31, 2014 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Equity Note Disclosure [Text Block] | NOTE 2 – Stockholders’ Equity |
Common Stock | |
The Company has authorized 750,000,000 shares of common stock, $0.001 par value. | |
On September 13, 2010 the Company closed a share exchange transaction (the “Reorganization”) with the shareholders of B6 Sigma, Inc., a Delaware corporation (“B6 Sigma”), which resulted in B6 Sigma becoming a wholly-owned subsidiary of the Company. Each share of B6 Sigma, Inc. common stock outstanding as at the closing of the Reorganization was exchanged for 6.67 shares of the Company’s common stock. At the closing, B6 Sigma, Inc. also acquired and cancelled 110,700,000 (post-split) shares of the Company’s common stock from three shareholders for the sum of $195,000. Upon the closing of the Reorganization, the Company ceased to be a “Shell” company (as such term is defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended). As a condition to the closing of the Reorganization, B6 Sigma, Inc. also closed a private offering of $1,000,000 of its common stock contemporaneously with the closing of the Reorganization, which included the conversion of $300,000 of previously issued convertible notes and related interest by B6 Sigma, Inc. into the private offering of common stock. | |
Following issuance of the Reorganization shares to the B6 Sigma shareholders and the stock cancellation, the Company had 313,067,400 (post-split) shares of its common stock issued and outstanding. In connection with the closing of the Reorganization, the shareholders of the Company approved a 150:1 forward stock split, and a change of the name of the corporation to Sigma Labs, Inc. Additionally, following completion of the Reorganization, B6 Sigma became a wholly owned subsidiary of the Company. | |
In January 2011, the Company commenced a private offering of up to 75,000,000 shares of common stock, $0.001 par value per share, at a price of $0.02 per share of common stock. On April 15, 2011, the Company closed the private offering, pursuant to which the Company issued 55,875,000 shares of the Company’s common stock. Gross proceeds amounted to $1,117,500. | |
The placement agent received a total of $105,735 in commissions. The direct cost associated with the stock offering has been reflected as a reduction to Additional Paid-in-Capital. Net proceeds from the sale of stock were $1,011,765. The Company also issued to the agent five year warrants to purchase up to 7,931,250 shares of the Company’s common stock. Such warrants had an exercise price of $0.025 per share and were valued at $158,625. During July 2013, such warrants were exercised using the cashless exercise option resulting in 5,098,661 shares being issued. | |
The fair value of the warrants issued was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions: risk free interest rate of 2.14%; Volatility of 470 and an expected life of five years. It is assumed that no dividends will be paid during the periods of calculation, resulting in a respective weighted-average fair value per warrant of $0.02. Management believes the resulting warrant values are reasonable. | |
On March 9, 2011, our Board of Directors adopted the 2011 Equity Incentive Plan (the “2011 Plan”). On March 31, 2011, the holders of at least a majority of the issued and outstanding shares of common stock of the Company approved the 2011 Plan. Pursuant to the 2011 Plan, the Company is authorized to grant options, restricted stock and stock appreciation rights to purchase up to 31,000,000 shares of common stock to its employees, officers, directors, consultants and advisors. The 2011 Plan provides for awards of incentive stock options, non-statutory stock options, and rights to acquire stock with and without restrictions. Incentive stock options granted under the 2011 Plan are intended to qualify as “incentive stock options” within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”). Non-statutory stock options granted under the 2011 Plan are not intended to qualify as incentive stock options under the Code. | |
On January 31, 2013, the Company issued 250,000 shares of the Company’s common stock to a consultant as noncash compensation for services to be rendered valued at $7,500 or $0.03 per share. | |
On February 14, 2013, the Company issued 4,000,000 shares of the Company’s common stock to a consultant as noncash compensation for services to be rendered valued at $120,000 or $0.03 per share. Of these shares, 1,250,000 (valued at $37,500) vested during the six months ended June 30, 2013 and 2,750,000 (valued at $82,500) were cancelled in June 2013. | |
On March 15, 2013, the Company’s Board of Directors approved the Company’s 2013 Equity Incentive Plan (the “2013 Plan”). The 2013 Plan was approved by holders of at least a majority of the issued and outstanding shares of common stock of the Company on October 10, 2013. Pursuant to the 2013 Plan, the Company is authorized to grant options, shares of common stock with and without restrictions, and stock appreciation rights to purchase up to 30,000,000 shares of common stock to its employees, officers, directors, consultants and advisors. | |
On May 10, 2013, the Company issued 500,000 shares of the Company’s common stock to a consultant as noncash compensation for services rendered valued at $12,400 or $0.0248 per share. | |
On May 23, 2013, the Company issued 2,000,000 shares of the Company’s common stock to a consultant as noncash compensation for services to be rendered valued at $45,400 or $0.0227 per share. Of these shares, 1,000,000 (valued at $22,700) vested immediately and 1,000,000 (valued at $22,700) remain unvested and are reflected as deferred compensation as of December 31, 2014. | |
On July 18, 2013, the Company completed a private placement of 120,000,000 shares of common stock, resulting in aggregate gross proceeds of $1,200,000. Offering costs were approximately $30,054. | |
During July 2013, warrants previously issued during 2011 in connection with a private placement were exercised using the cashless exercise option resulting in 5,098,661 shares being issued. | |
On August 12, 2013, the Company issued 500,000 shares of the Company’s common stock to a consultant as noncash compensation for services rendered valued at $31,500 or $0.063 per share. | |
On August 26, 2013, the Company issued 1,000,000 shares of the Company’s common stock to a director pursuant to the 2011 Plan valued at $65,000 or $0.065 per share. | |
On October 31, 2013, in conjunction with the appointment of a director as a member of the Company’s Board of Directors, the Company issued 500,000 shares of the Company’s common stock to the director pursuant to the 2011 Plan as noncash compensation valued at $78,000 or $0.156 per share. Of these shares, 300,000 (valued at $46,800) vested immediately and 200,000 (valued at $31,200) vested during 2014. | |
In January 2014, the Company issued 43,750,000 shares of stock to an investor for a total purchase price of $3,500,000. In connection with the purchase and sale of the shares, the Company agreed to issue to the investor a warrant to purchase up to 14,259,259 shares of the Company’s common stock, at an exercise price of $0.15 per share. The warrant has a term of nine months from the date of issuance (January 10, 2014) and had a fair value of approximately $1,212,037. In May 2014, the term of the warrant was extended by nine months to expire in July 2015 and had a fair market value in excess of the remaining fair market value of the original warrant of approximately $1,283,333. A warrant was also issued as part of the offering to a consultant to purchase up to 2,187,500 shares of common stock at $0.08 per share, valued at approximately $271,250. The warrant has a term of two years from the date of issuance (January 10, 2014). Offering costs paid from the proceeds of the offering were approximately $199,089. | |
The fair value of the warrant of $1,212,037 was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of nine months, expected volatility of 202%, a risk-free interest rate of 0.09%, and an expected dividend yield of 0%. The fair value of the warrant of $271,250 was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of two years, expected volatility of 201%, a risk-free interest rate of 0.39%, and an expected dividend yield of 0%. | |
The fair value of the new warrant related to the extension of the warrant expiration of $1,283,333 (net) was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of 14 months, expected volatility of 226%, a risk-free interest rate of 0.1%, and an expected dividend yield of 0%. | |
In February 2014, the Company issued 375,000 shares of stock to a consultant, subject to restrictions. The shares were valued at $0.126 or $47,250. Of these shares, 200,000 (valued at $25,200) vested during the quarter ended March 31, 2014 and 175,000 (valued at $22,050) vested during the quarter ended September 30, 2014. | |
In April 2014, the Company issued 850,000 shares of common stock to two employees and one director for services valued at $0.136 per share or $115,600. | |
In June 2014, the Company issued 1,250,000 shares of common stock to a consultant as noncash compensation for services to be rendered valued at $0.128 per share or $160,000. | |
In June 2014, the Company issued 6,250,000 shares of stock to an investor for a total purchase price of $500,000. In connection with the purchase and sale of the shares, the Company agreed to issue to the investor a warrant to purchase up to 2,037,037 shares of the Company’s common stock, at an exercise price of $0.15 per share. The warrant has a term of one year from the date of issuance (June 4, 2014) and had a fair value of approximately $132,407. A warrant was also issued as part of the offering to a consultant to purchase up to 312,500 shares of common stock at $0.08 per share, valued at approximately $36,250. The warrant has a term of two years from the date of issuance (June 4, 2014). Offering costs paid from the proceeds of the offering were approximately $25,035. | |
The fair value of the warrant of $132,407 was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of one year, expected volatility of 163%, a risk-free interest rate of 0.1%, and an expected dividend yield of 0%. The fair value of the warrant of $36,250 was calculated using a Black-Scholes option pricing model with the following assumptions: expected life of two years, expected volatility of 287%, a risk-free interest rate of 0.41%, and an expected dividend yield of 0%. | |
In November 2014, the Company issued 1,500,000 shares of stock to a director, subject to restrictions, pursuant to the 2013 Plan. The shares were valued at $0.094 or $141,000. The shares are scheduled to vest quarterly during 2015. | |
The Company has authorized 750,000,000 shares of common stock, $0.001 par value. At December 31, 2014, there were 619,741,061 shares issued and 612,741,061 outstanding, reflecting 7,000,000 issued but unvested shares pursuant to the 2011 Plan and the 2013 Plan. At December 31, 2013, there were 559,766,061 shares issued and 556,816,061 shares outstanding, reflecting 2,950,000 issued but unvested shares pursuant to the 2011 Plan. As of December 31, 2014, an aggregate of 150,000 shares and 21,250,000 shares of common stock were reserved for issuance under the 2011 Plan and the 2013 Plan, respectively, including 1,000,000 shares and 6,000,000 shares subject to vesting restrictions under the 2011 Plan and the 2013 Plan, respectively. | |
Deferred Compensation | |
During April 2011, the Company issued to five employees an aggregate of 20,000,000 shares of the Company’s common stock, subject to restrictions, pursuant to the 2011 Plan. Such shares were valued at the fair value of $400,000 or $0.02 per share. This compensation has been expensed over the vesting period. | |
During the year ended December 31, 2012, 7,000,000 shares of unvested common stock valued at $140,000 (previously included in deferred compensation) were cancelled or forfeited. | |
During the year ended December 31, 2012, an additional 3,750,000 shares of common stock valued at $75,000 vested and were recorded to expense and as a reduction to deferred compensation. | |
During the year ended December 31, 2013, 500,000 shares of unvested common stock valued at $10,000 (previously included in deferred compensation) were cancelled or forfeited. | |
During the year ended December 31, 2013, an additional 1,750,000 shares of common stock valued at $35,000 vested and were recorded to expense and as a reduction to deferred compensation. | |
During the year ended December 31, 2013, 4,250,000 shares of common stock were issued to consultants at $0.03 per share, 500,000 shares were issued to a consultant at $0.0248 per share, 2,000,000 shares were issued to a consultant at $0.0227 per share, 500,000 shares were issued to a consultant at $0.063 per share, 1,000,000 shares were issued to a consultant at $0.065 per share and 500,000 shares were issued to a director at $0.156 per share. The unvested portion of the shares at December 31, 2013 (1,200,000 unvested shares) increased deferred compensation by $53,900. | |
As of December 31, 2013, the balance of unvested compensation cost expected to be recognized was $88,900 and was recorded as a reduction of stockholders’ equity. The unvested compensation was expected to be recognized over the weighted average period of approximately 1 year (through April 8, 2014). | |
During the year ended December 31, 2014, 375,000 shares of common stock were issued to a consultant at $0.126 per share. | |
During the year ended December 31, 2014, an additional 1,750,000 shares of common stock valued at $35,000 vested and were recorded to expense and as a reduction to deferred compensation. | |
During July 2014, the Company issued to three employees an aggregate of 6,000,000 shares of the Company’s common stock, subject to restrictions, pursuant to the 2013 Plan. Such shares were valued at the fair value of $774,000 or $0.129 per share. This compensation is being expensed over the vesting period. As of December 31, 2014, the balance of unvested compensation cost expected to be recognized is $580,500 (4,500,000 shares valued at $0.129) and is recorded as a reduction of stockholders’ equity. The unvested compensation is expected to be recognized over the weighted average period of approximately 3 years (through July 2017). | |
In November 2014, the Company issued 1,500,000 shares of stock to a director, subject to restrictions. The shares were valued at $0.094 or $141,000. The shares are scheduled to vest quarterly during 2015 and have increased deferred compensation by $141,000. | |
As of December 31, 2014, the balance of unvested compensation cost expected to be recognized is $744,200 and is recorded as a reduction of stockholders’ equity. The unvested compensation is expected to be recognized over the weighted average period of approximately 3 years (through July, 2017). | |
Preferred Stock | |
The Company is authorized to issue 10,000,000 shares of preferred stock, $0.001 par value. There were none issued and outstanding at December 31, 2014 and December 31, 2013. | |
Warrants | |
At December 31, 2014, the Company had four outstanding warrants for a total of 18,796,296 shares. Of these, 16,296,296 are exercisable at $0.15 per share and 2,500,000 are exercisable at $0.08 per shares. | |
During July 2013, warrants which had been issued in January 2011 as part of a private offering were exercised using the cashless exercise option resulting in 5,098,661 shares being issued. | |
There were no warrants that expired during the years ending December 31, 2014 or 2013. | |
Registration_Statement_on_Form
Registration Statement on Form S-3 | 12 Months Ended |
Dec. 31, 2014 | |
Registration Statement [Abstract] | |
Registration Statement [Text Block] | NOTE 3 – Registration Statement on Form S-3 |
As previously reported, during September 2014, the Company filed a Registration Statement on Form S-3 with the SEC, which was declared effective by the SEC on December 19, 2014. The Registration Statement covers the offer and sale, from time to time, up to $100,000,000 of securities of the Company, including shares of the Company's common stock and preferred stock, debt securities and warrants, either individually or in units, the terms of which will be described in prospectus supplements filed with the SEC, as applicable. Concurrently with the filing of the Registration Statement, the Company entered into an At The Market Offering Agreement, or sales agreement, with Ascendiant Capital Markets, LLC (“Ascendiant”), pursuant to which the Company may offer and sell from time to time through Ascendiant, acting as sales agent and/or principal, shares of our common stock having an aggregate offering price of up to $25,000,000. We have agreed to pay Ascendiant a commission rate of 3% of the gross sales price per share of any of our shares of common stock sold through Ascendiant, as agent, under the sales agreement. The offer and sale of our shares through Ascendiant will be registered pursuant to the Registration Statement. As of December 31, 2014 no securities have been sold under the Registration Statement. As of March 31, 2015, the Company is not eligible to use the Registration Statement because the aggregate market value of the Company’s outstanding common stock held by non-affiliates of the Company is less than the minimum required by General Institution I.B.1 of Form S-3 (i.e., $75 million). | |
Continuing_Operations
Continuing Operations | 12 Months Ended |
Dec. 31, 2014 | |
Continuing Operations Disclosure [Abstract] | |
Continuing Operations Disclosure [Text Block] | NOTE 4 – Continuing Operations |
The Company has sustained losses and has negative cash flows from operating activities since its inception. The Company has also had decreasing revenues in recent periods. However, the Company has raised significant equity capital and is currently developing new product lines to increase future revenues. Management believes they have adequate working capital and cash to fund operations through 2015, and has entered into significant revenue contracts that are expected to generate cash flow in the near-term. | |
Income_Taxes
Income Taxes | 12 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Income Tax Disclosure [Abstract] | ||||||||
Income Tax Disclosure [Text Block] | NOTE 5 – Income Taxes | |||||||
The Company accounts for income taxes in accordance with ASC Topic No. 740. This standard requires the Company to provide a net deferred tax asset or liability equal to the expected future tax benefit or expense of temporary reporting differences between book and tax accounting methods and any available operating loss or tax credit carryforwards. | ||||||||
The Company has available at December 31, 2014, unused operating loss carryforwards of approximately $4,435,042, which may be applied against future taxable income and which expire in various years through 2034. However, if certain substantial changes in the Company’s ownership should occur, there could be an annual limitation on the amount of net operating loss carryforward which can be utilized. The amount of and ultimate realization of the benefits from the operating loss carryforwards for income tax purposes is dependent, in part, upon the tax laws in effect, the future earnings of the Company and other future events, the effects of which cannot be determined. Because of the uncertainty surrounding the realization of the loss carryforwards, the Company has established a valuation allowance equal to the tax effect of the loss carryforwards of approximately $2,255,520 and $1,044,923 at December 31, 2014 and 2013, respectively, and, therefore, no deferred tax asset has been recognized for the loss carryforwards. The change in the valuation allowance is approximately $1,210,597 and $314,037 for the years ended December 31, 2014 and 2013, respectively. | ||||||||
Deferred tax assets are comprised of the following: | ||||||||
2014 | 2013 | |||||||
Deferred tax assets: | ||||||||
NOL carryover | $ | 1,723,014 | $ | 1,010,992 | ||||
Impairments | 33,931 | 33,931 | ||||||
Warrants | 498,575 | - | ||||||
Valuation allowance | -2,255,520 | -1,044,923 | ||||||
Net deferred tax asset | $ | 0 | $ | 0 | ||||
The reconciliation of the provision for income taxes computed at the U.S. federal statutory tax rate to the Company’s effective tax rate for the period ended December 31, 2014 and 2013 is as follows: | ||||||||
2014 | 2013 | |||||||
Book Loss | $ | 1,059,467 | $ | 249,600 | ||||
State taxes | 151,130 | 35,605 | ||||||
Deductible differences | - | 28,832 | ||||||
Change in valuation allowance | -1,210,597 | -314,037 | ||||||
Provision for Income Taxes | $ | - | $ | - | ||||
Loss_Per_Share
Loss Per Share | 12 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Earnings Per Share [Abstract] | ||||||||
Earnings Per Share [Text Block] | NOTE 6 – Loss Per Share | |||||||
The following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of dilutive potential common stock for the periods ended December 31, 2014 and 2013: | ||||||||
Year Ended December 31 | ||||||||
2014 | 2013 | |||||||
Loss from continuing | ||||||||
Operations available to | ||||||||
Common stockholders (numerator) | $ | -3,116,080 | $ | -734,117 | ||||
Weighted average number of | ||||||||
common shares Outstanding | ||||||||
used in loss per share during | ||||||||
the Period (denominator) | 610,344,691 | 489,921,337 | ||||||
Dilutive loss per share was not presented as the Company had no common equivalent shares for all periods presented that would affect the computation of diluted loss per share or its effect is anti-dilutive. | ||||||||
Furniture_and_Equipment
Furniture and Equipment | 12 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Property, Plant and Equipment [Abstract] | ||||||||
Property, Plant and Equipment Disclosure [Text Block] | NOTE 7 – Furniture and Equipment | |||||||
3D Metal Printer – On August 14, 2014, the Company and EOS GmbH (EOS) finalized their agreement with respect to the purchase by the Company of a state-of-the art 3D metal printer Model M290 from EOS for purposes of making parts for users of performance and safety critical components. The printer will also serve as an in-house test bed for future upgrades to the Company’s commercially available PrintRite 3D quality assurance system. As of December 31, 2014, the Company has capitalized $732,028 towards the purchase. | ||||||||
The following is a summary of property and equipment, purchased, used and depreciated over a three-year period, less accumulated depreciation, as of December 31, 2014 and 2013: | ||||||||
Year Ended December 31, | ||||||||
2014 | 2013 | |||||||
Property and Equipment | $ | 924,319 | $ | 112,371 | ||||
Less: Accumulated Depreciation | -121,292 | -100,952 | ||||||
Net Property and Equipment | $ | 803,027 | $ | 11,419 | ||||
Depreciation expense on property and equipment was $20,340 and $10,587 for the years ended December 31, 2014 and 2013, respectively. | ||||||||
Intangible_Assets
Intangible Assets | 12 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ||||||||
Intangible Assets Disclosure [Text Block] | NOTE 8 – Intangible Assets | |||||||
The Company’s intangible assets consist of Patents, Patent Pending Applications and Customer Contacts. | ||||||||
Provisional patent applications are not amortized until a patent has been granted. Once a patent is granted, the Company will amortize the related costs over the estimated useful life of the patent. If a patent application is denied, then the costs will be expensed at that time. | ||||||||
The customer contacts were acquired in a business acquisition on December 31, 2011 and were to be amortized over their estimated useful life of 3 years. | ||||||||
The following is a summary of definite-life intangible assets less accumulated amortization as of December 31, 2014 and 2013, respectively: | ||||||||
Year Ended December 31, | ||||||||
2014 | 2013 | |||||||
Provisional Patent Applications | $ | 63,823 | $ | 36,161 | ||||
Patents | 39,252 | 39,252 | ||||||
Customer Contacts | 262,009 | 262,009 | ||||||
Less: Accumulated Amortization | -269,237 | -266,928 | ||||||
Net Intangible Assets | $ | 95,847 | $ | 70,494 | ||||
Amortization expense on intangible assets was $2,309 and $89,513 for the years ended December 31, 2014 and 2013. In addition, an impairment of customer contacts in the amount of $87,340 was recorded in the year ending December 31, 2013. | ||||||||
The estimated aggregate amortization expense for each of the succeeding years ending December 31 is as follows: | ||||||||
2015 | $ | 2,309 | ||||||
2016 | 2,309 | |||||||
2017 | 2,309 | |||||||
2018 | 2,309 | |||||||
2019 | 2,309 | |||||||
Thereafter | 20,479 | |||||||
$ | 32,024 | |||||||
Commitments_and_Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2014 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies Disclosure [Text Block] | NOTE 9 – Commitments and Contingencies |
Operating Leases – The Company leases office and laboratory space under operating leases. Expense relating to these operating leases was $46,798 for the year ended December 31, 2014. The future minimum lease payments required under non-cancellable operating leases at December 31, 2014 was approximately $27,000. All the future minimum lease payments are currently due during 2015. | |
Concentrations
Concentrations | 12 Months Ended | |||||
Dec. 31, 2014 | ||||||
Risks and Uncertainties [Abstract] | ||||||
Concentration Risk Disclosure [Text Block] | NOTE 10 – Concentrations | |||||
Revenues – During the years ended December 31, 2014 and 2013, the Company had the following significant customers who accounted for more than 10% each of the Company’s revenue in at least one of the periods presented. The loss of the revenues generated by these customers would have a significant effect on the operations of the Company. | ||||||
Customer | 2014 | 2013 | ||||
A | 30% | 22% | ||||
B | 27% | 19% | ||||
C | 21% | 0% | ||||
D | 18% | 50% | ||||
Accounts Receivable – The Company had the following significant customers who accounted for more than 10% each of the Company’s accounts receivable balance at December 31, 2014 and 2013, respectively. | ||||||
Customer | 2014 | 2013 | ||||
A | 16% | 19% | ||||
B | 50% | 31% | ||||
C | 13% | 0% | ||||
D | 0% | 39% | ||||
E | 20% | 4% | ||||
Subsequent_Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2014 | |
Subsequent Events [Abstract] | |
Subsequent Events [Text Block] | NOTE 11 – Subsequent Events |
The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and determined there are the following items to disclose: | |
In March 2015, the Company issued an aggregate of 2,603,774 shares of common stock, subject to vesting restrictions, to an officer and two consultants of the Company, and 1,000,000 shares of common stock to a director, under the 2013 Plan. | |
Summary_of_Significant_Account1
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2014 | |
Accounting Policies [Abstract] | |
Basis of Accounting, Policy [Policy Text Block] | Basis of Presentation – The accompanying consolidated financial statements have been prepared by the Company in accordance with Article 8 of U.S. Securities and Exchange Commission Regulation S-X. |
Reclassification, Policy [Policy Text Block] | Reclassification – Certain amounts in prior-period financial statements have been reclassified for comparative purposes to conform to presentation in the current-period financial statements. |
Consolidation, Policy [Policy Text Block] | Principles of Consolidation – The consolidated financial statements for December 31, 2014 include the accounts of Sigma Labs, Inc., B6 Sigma, Inc. and Sumner & Lawrence Limited. All significant intercompany balances and transactions have been eliminated. |
Property, Plant and Equipment, Policy [Policy Text Block] | Property and Equipment – Property and equipment are stated at cost. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized upon being placed in service. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated life has been determined to be three years unless a unique circumstance exists, which is then fully documented as an exception to the policy. |
Fair Value of Financial Instruments, Policy [Policy Text Block] | Fair Value of Financial Instruments – The Company estimates that the fair value of all financial instruments does not differ materially from the aggregate carrying values of its financial instruments recorded in the accompanying consolidated balance sheets because of the short-term maturity of these financial instruments. |
Income Tax, Policy [Policy Text Block] | Income Taxes – The Company accounts for income taxes in accordance with ASC Topic No. 740, “Accounting for Income Taxes.” |
The Company adopted the provisions of ASC Topic No. 740, “Accounting for Income Taxes,” at the date of inception on February 5, 2010. As a result of the implementation of ASC Topic No. 740, the Company recognized no increase in the liability for unrecognized tax benefits. | |
The Company has no tax positions at December 31, 2014 and 2013 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. | |
The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the year ended December 31, 2014, the Company recognized no interest and penalties. The Company had no accruals for interest and penalties at December 31, 2014 or 2013. All tax years starting with 2010 are open for examination. | |
Earnings Per Share, Policy [Policy Text Block] | Loss Per Share – The computation of loss per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, “Earnings Per Share.” |
Trade and Other Accounts Receivable, Policy [Policy Text Block] | Accounts Receivable and Allowance for Doubtful Accounts - Trade accounts receivable are carried at original invoice amount less an estimate made for doubtful accounts. We determine the allowance for doubtful accounts by identifying potential troubled accounts and by using historical experience and future expectations applied to an aging of accounts. Trade accounts receivable are written off when deemed uncollectible. Recoveries of trade accounts receivable previously written off are recorded as income when received. The allowance for doubtful accounts at December 31, 2014 and 2013 was $4,884 and $4,884 respectively. |
Goodwill and Intangible Assets, Policy [Policy Text Block] | Long-Lived and Intangible Assets – Long-lived assets and certain identifiable definite life intangibles to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company continuously evaluates the recoverability of its long-lived assets based on estimated future cash flows and the estimated liquidation value of such long-lived assets, and provides for impairment if such undiscounted cash flows are insufficient to recover the carrying amount of the long-lived assets. If impairment exists, an adjustment is made to write the asset down to its fair value, and a loss is recorded as the difference between the carrying value and fair value. Fair values are determined based on quoted market values, discounted cash flows or internal and external appraisals, as applicable. Assets to be disposed of are carried at the lower of carrying value or estimated net realizable value. No impairment was recorded in the year ended December 31, 2014. During the year ended December 31, 2013, an impairment of $87,340 was recorded to reduce the value of customer contacts intangible assets of Sumner as management had planned to discontinue servicing the related contracts in 2014. |
New Accounting Pronouncements, Policy [Policy Text Block] | Recently Enacted Accounting Standards – The FASB established the Accounting Standards Codification (“Codification” or “ASC”) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States (“GAAP”). Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) issued under authority of federal securities laws are also sources of GAAP for SEC registrants. |
Recent Accounting Standards Updates (“ASU”) through ASU No. 2014-16 contain technical corrections to existing guidance or affects guidance to specialized industries. These updates have no current applicability to the Company or their effect on the financial statements would not have been significant. | |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash Equivalents - The Company considers all highly liquid investments with an original maturity of three months or less at date of purchase to be cash equivalents. |
Concentration Risk, Credit Risk, Policy [Policy Text Block] | Concentration of Credit Risk - The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents. |
Organization Expenditure [Policy Text Block] | Organization Expenditures – Organizational expenditures are expensed as incurred for SEC filings, but capitalized and amortized for income tax purposes. |
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] | Stock Based Compensation – The Company recognizes compensation costs to employees under ASC Topic No. 718, “Compensation – Stock Compensation.” Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with and without restrictions, performance based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option or stock grants. Unvested option or stock grant for compensation are included in the Statement of Shareholders Equity as a contra-equity account as “Deferred Compensation”. |
Equity instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 505, “Equity Based Payments to Non-Employees.” In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that (i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards Codification. | |
Depreciation, Depletion, and Amortization [Policy Text Block] | Amortization - Utility patents are amortized over a 17 year period. Patents which are pending are not amortized. The customer contacts intangible asset was being amortized over a 3 year period. |
Use of Estimates, Policy [Policy Text Block] | Accounting Estimates - The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowances for bad debts and inventory obsolescence. |
Revenue Recognition, Policy [Policy Text Block] | Revenue Recognition – The Company’s revenue is derived primarily from providing services under contracts. The Company recognizes revenue in accordance with ASC Topic No. 605 based on the following criteria: Persuasive evidence of an arrangement exists, services have been rendered, the price is fixed or determinable, and collectability is reasonably assured. In general, the Company recognizes service revenue as significant services under the relevant arrangement have been performed. |
Deferred Stock Offering Costs [Policy Text Block] | Deferred Stock Offering Costs – Costs related to proposed stock offerings if any are deferred and will be offset against the proceeds of the offering in additional paid-in capital. In the event a stock offering is unsuccessful, the costs relating to the offering will be written-off directly to expense. |
Inventory, Policy [Policy Text Block] | Inventory – Inventories consist of raw materials used in the production of customized parts totaling $11,242 and work in process components totaling $44,933 which will be sold to customers. Inventories are valued at the lower of cost or market. |
Research and Development Expense, Policy [Policy Text Block] | Research and Development – Research and development costs are expensed as they are incurred. Research and development costs for the years ended December 31, 2014 and 2013 were $219,132 and $14,275, respectively. |
Income_Taxes_Tables
Income Taxes (Tables) | 12 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Income Tax Disclosure [Abstract] | ||||||||
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] | Deferred tax assets are comprised of the following: | |||||||
2014 | 2013 | |||||||
Deferred tax assets: | ||||||||
NOL carryover | $ | 1,723,014 | $ | 1,010,992 | ||||
Impairments | 33,931 | 33,931 | ||||||
Warrants | 498,575 | - | ||||||
Valuation allowance | -2,255,520 | -1,044,923 | ||||||
Net deferred tax asset | $ | 0 | $ | 0 | ||||
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] | The reconciliation of the provision for income taxes computed at the U.S. federal statutory tax rate to the Company’s effective tax rate for the period ended December 31, 2014 and 2013 is as follows: | |||||||
2014 | 2013 | |||||||
Book Loss | $ | 1,059,467 | $ | 249,600 | ||||
State taxes | 151,130 | 35,605 | ||||||
Deductible differences | - | 28,832 | ||||||
Change in valuation allowance | -1,210,597 | -314,037 | ||||||
Provision for Income Taxes | $ | - | $ | - | ||||
Loss_Per_Share_Tables
Loss Per Share (Tables) | 12 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Earnings Per Share [Abstract] | ||||||||
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | The following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of dilutive potential common stock for the periods ended December 31, 2014 and 2013: | |||||||
Year Ended December 31 | ||||||||
2014 | 2013 | |||||||
Loss from continuing | ||||||||
Operations available to | ||||||||
Common stockholders (numerator) | $ | -3,116,080 | $ | -734,117 | ||||
Weighted average number of | ||||||||
common shares Outstanding | ||||||||
used in loss per share during | ||||||||
the Period (denominator) | 610,344,691 | 489,921,337 | ||||||
Furniture_and_Equipment_Tables
Furniture and Equipment (Tables) | 12 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Property, Plant and Equipment [Abstract] | ||||||||
Property, Plant and Equipment [Table Text Block] | The following is a summary of property and equipment, purchased, used and depreciated over a three-year period, less accumulated depreciation, as of December 31, 2014 and 2013: | |||||||
Year Ended December 31, | ||||||||
2014 | 2013 | |||||||
Property and Equipment | $ | 924,319 | $ | 112,371 | ||||
Less: Accumulated Depreciation | -121,292 | -100,952 | ||||||
Net Property and Equipment | $ | 803,027 | $ | 11,419 | ||||
Intangible_Assets_Tables
Intangible Assets (Tables) | 12 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ||||||||
Schedule of Finite-Lived Intangible Assets [Table Text Block] | The following is a summary of definite-life intangible assets less accumulated amortization as of December 31, 2014 and 2013, respectively: | |||||||
Year Ended December 31, | ||||||||
2014 | 2013 | |||||||
Provisional Patent Applications | $ | 63,823 | $ | 36,161 | ||||
Patents | 39,252 | 39,252 | ||||||
Customer Contacts | 262,009 | 262,009 | ||||||
Less: Accumulated Amortization | -269,237 | -266,928 | ||||||
Net Intangible Assets | $ | 95,847 | $ | 70,494 | ||||
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] | The estimated aggregate amortization expense for each of the succeeding years ending December 31 is as follows: | |||||||
2015 | $ | 2,309 | ||||||
2016 | 2,309 | |||||||
2017 | 2,309 | |||||||
2018 | 2,309 | |||||||
2019 | 2,309 | |||||||
Thereafter | 20,479 | |||||||
$ | 32,024 | |||||||
Concentrations_Tables
Concentrations (Tables) | 12 Months Ended | |||||
Dec. 31, 2014 | ||||||
Risks and Uncertainties [Abstract] | ||||||
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] | Revenues – During the years ended December 31, 2014 and 2013, the Company had the following significant customers who accounted for more than 10% each of the Company’s revenue in at least one of the periods presented. The loss of the revenues generated by these customers would have a significant effect on the operations of the Company. | |||||
Customer | 2014 | 2013 | ||||
A | 30% | 22% | ||||
B | 27% | 19% | ||||
C | 21% | 0% | ||||
D | 18% | 50% | ||||
Schedule Of Accounts Receivable By Major Customers By Reporting Segments [Table Text Block] | Accounts Receivable – The Company had the following significant customers who accounted for more than 10% each of the Company’s accounts receivable balance at December 31, 2014 and 2013, respectively. | |||||
Customer | 2014 | 2013 | ||||
A | 16% | 19% | ||||
B | 50% | 31% | ||||
C | 13% | 0% | ||||
D | 0% | 39% | ||||
E | 20% | 4% | ||||
Summary_of_Significant_Account2
Summary of Significant Accounting Policies (Details Textual) (USD $) | 0 Months Ended | 12 Months Ended | ||
Sep. 13, 2010 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2011 | |
Summary Of Significant Accounting Policies [Line Items] | ||||
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions | 100.00% | |||
Number Of Shares Exchanged For Each Share Of Acquired Entity (in shares) | 6.67 | |||
Allowance for Doubtful Accounts Receivable, Current | $4,884 | $4,884 | ||
Finite-Lived Intangible Assets, Useful Life, Maximum | 3 years | |||
Impairment of Intangible Assets, Finite-lived | 0 | 87,340 | ||
Research and Development Expense | 219,132 | 14,275 | ||
Inventory, Raw Materials, Gross | 11,242 | |||
Inventory, Work in Process, Gross | $44,933 | |||
Sumner and La Mancha [Member] | ||||
Summary Of Significant Accounting Policies [Line Items] | ||||
Stock Issued During Period, Shares, Purchase Of Assets (in shares) | 35,000,000 | |||
Business Acquisition, Percentage of Voting Interests Acquired | 100.00% | |||
Patents [Member] | ||||
Summary Of Significant Accounting Policies [Line Items] | ||||
Finite-Lived Intangible Assets, Useful Life, Maximum | 17 years | |||
Customer Contacts [Member] | ||||
Summary Of Significant Accounting Policies [Line Items] | ||||
Finite-Lived Intangible Assets, Useful Life, Maximum | 3 years |
Stockholders_Equity_Details_Te
Stockholders' Equity (Details Textual) (USD $) | 0 Months Ended | 1 Months Ended | 9 Months Ended | 12 Months Ended | 1 Months Ended | 3 Months Ended | 6 Months Ended | 1 Months Ended | 12 Months Ended | |||||||||||||||||
Mar. 15, 2013 | Sep. 13, 2010 | Nov. 30, 2014 | 31-May-14 | Jan. 31, 2011 | Sep. 30, 2014 | Dec. 31, 2014 | Dec. 31, 2013 | Jun. 30, 2014 | Jan. 31, 2014 | Oct. 31, 2013 | Aug. 31, 2013 | Apr. 30, 2011 | Mar. 31, 2011 | Jul. 31, 2014 | Feb. 28, 2014 | 31-May-13 | Feb. 28, 2013 | Jan. 31, 2013 | Mar. 31, 2014 | Jun. 30, 2013 | Jul. 31, 2013 | Dec. 31, 2012 | Apr. 30, 2014 | Aug. 12, 2013 | Feb. 14, 2013 | |
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Common stock, shares authorized | 750,000,000 | 750,000,000 | ||||||||||||||||||||||||
Common stock, par value (in dollars per share) | $0.00 | $0.00 | ||||||||||||||||||||||||
Common stock, share issued | 619,741,061 | 559,766,061 | ||||||||||||||||||||||||
Stock Issued During Period, Value, Issued For Noncash Considerations | $175,000 | |||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | 88,250 | 35,000 | ||||||||||||||||||||||||
Preferred stock, shares authorized | 10,000,000 | 10,000,000 | ||||||||||||||||||||||||
Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | ||||||||||||||||||||||||
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized | 744,200 | 88,900 | ||||||||||||||||||||||||
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized, Period For Recognition | 3 years | 1 year | ||||||||||||||||||||||||
Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance | 7,000,000 | 2,950,000 | ||||||||||||||||||||||||
Placement Agent Commissions Received | 105,735 | |||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 7,931,250 | 5,098,661 | 312,500 | 5,098,661 | ||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $0.03 | $0.15 | ||||||||||||||||||||||||
Proceeds from Issuance of Warrants | 158,625 | |||||||||||||||||||||||||
Net Proceeds from Sale of Common Stock | 1,011,765 | |||||||||||||||||||||||||
Cancellation Of Common Stock Value | 110,700,000 | |||||||||||||||||||||||||
Stock Issued During Period, Shares, Stock Splits | 313,067,400 | |||||||||||||||||||||||||
Number Of Shares Exchanged For Each Share Of Acquired Entity (in shares) | 6.67 | |||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | 2.14% | |||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | 470.00% | |||||||||||||||||||||||||
Share Based Compensation Arrangement By Share Based Payment Award Warrants Grants In Period Weighted Average Grant Date Fair Value | $0.02 | |||||||||||||||||||||||||
Cancellation Of Common Stock Pursuant To Private Offering | 1,000,000 | |||||||||||||||||||||||||
Convertible Notes Value Included In Cancellation Of Common Stock | 300,000 | |||||||||||||||||||||||||
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non vested Value | 10,000 | |||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | 494,300 | |||||||||||||||||||||||||
Payments of Stock Issuance Costs | 206,698 | |||||||||||||||||||||||||
Authorized Shares Of Common Stock Available To Employees | 30,000,000 | |||||||||||||||||||||||||
Share Based Compensation Arrangement By Share Based Payment Award Number Of Non Vested Fair Value | 141,000 | |||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues | 1,500,000 | 2,187,500 | ||||||||||||||||||||||||
Stock Issued During Period, Value, New Issues | 1,505,900 | |||||||||||||||||||||||||
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $0.08 | |||||||||||||||||||||||||
Class of Warrant or Right, Outstanding | 18,796,296 | |||||||||||||||||||||||||
Shares Issued, Price Per Share | $0.02 | $0.13 | ||||||||||||||||||||||||
Common Stock, Value, Issued | 619,741 | 559,766 | ||||||||||||||||||||||||
Fair Value Adjustment of Warrants | 1,283,333 | 1,283,333 | 0 | |||||||||||||||||||||||
Common Stock, Shares, Outstanding | 612,741,061 | 556,816,061 | ||||||||||||||||||||||||
Warrant [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 5,098,661 | |||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues | 14,259,259 | |||||||||||||||||||||||||
Warrants One [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Class Of Warrant Or Rights Exercisable | 16,296,296 | |||||||||||||||||||||||||
Warrants Two [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Class Of Warrant Or Rights Exercisable | 2,500,000 | |||||||||||||||||||||||||
Warrant Expiry Life One Year [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | 0.10% | |||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | 163.00% | |||||||||||||||||||||||||
Fair Value Adjustment of Warrants | 132,407 | |||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | 0.00% | |||||||||||||||||||||||||
Warrant Expiry Life Two Year [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | 0.39% | |||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | 287.00% | 201.00% | ||||||||||||||||||||||||
Fair Value Adjustment of Warrants | 36,250 | |||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | 0.00% | |||||||||||||||||||||||||
Warrant Expiry Life Nine Months [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | 0.09% | |||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | 202.00% | |||||||||||||||||||||||||
Fair Value Adjustment of Warrants | 1,212,037 | |||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | 0.00% | |||||||||||||||||||||||||
Warrant Expiry Life Fourteen Months [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | 0.10% | |||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | 226.00% | |||||||||||||||||||||||||
Fair Value Adjustment of Warrants | 1,283,333 | |||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | 0.00% | |||||||||||||||||||||||||
Director [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued For Noncash Consideration (in shares) | 500,000 | |||||||||||||||||||||||||
Stock Issued During Period, Value, Issued For Noncash Considerations | 78,000 | |||||||||||||||||||||||||
Share Based Compensation Arrangement By Share Based Payment Award Number Of Vested Shares (in shares) | 300,000 | |||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | 46,800 | |||||||||||||||||||||||||
Share Based Compensation Arrangement By Share Based Payment Award Number Of Non Vested Share | 200,000 | |||||||||||||||||||||||||
Share Based Compensation Arrangement By Share Based Payment Award Number Of Non Vested Fair Value | 31,200 | 53,900 | ||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 1,500,000 | |||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues | 1,500,000 | |||||||||||||||||||||||||
Stock Issued During Period, Value, New Issues | 141,000 | |||||||||||||||||||||||||
Shares Issued, Price Per Share | $0.09 | $0.09 | $0.16 | $0.16 | ||||||||||||||||||||||
Two Employees and One Director [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Common stock, par value (in dollars per share) | $0.14 | |||||||||||||||||||||||||
Common stock, share issued | 850,000 | |||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 850,000 | |||||||||||||||||||||||||
Shares Issued, Price Per Share | $0.14 | |||||||||||||||||||||||||
Common Stock, Value, Issued | 115,600 | |||||||||||||||||||||||||
Equity Incentive Plan 2011 [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Common stock, shares authorized | 556,816,061 | |||||||||||||||||||||||||
Common stock, share issued | 559,766,061 | |||||||||||||||||||||||||
Share Based Compensation Arrangement By Share Based Payment Award Number Of Vested Shares (in shares) | 1,000,000 | |||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 5,098,661 | |||||||||||||||||||||||||
Shares Issued For Employee Equity Plan | 20,000,000 | |||||||||||||||||||||||||
Stock Issued During Period, Value, Share-based Compensation, Gross | 400,000 | |||||||||||||||||||||||||
Shares Issued For Employee Equity Plan Par Value (in dollars per share) | $0.07 | $0.02 | ||||||||||||||||||||||||
Authorized Shares Of Common Stock Available To Employees | 31,000,000 | |||||||||||||||||||||||||
Common Stock, Capital Shares Reserved for Future Issuance | 150,000 | |||||||||||||||||||||||||
Common Stock, Shares, Outstanding | 2,950,000 | |||||||||||||||||||||||||
Equity Incentive Plan 2011 [Member] | Director [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Shares Issued For Employee Equity Plan | 1,000,000 | |||||||||||||||||||||||||
Stock Issued During Period, Value, Share-based Compensation, Gross | 65,000 | |||||||||||||||||||||||||
Equity Incentive Plan 2013 [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Common stock, shares authorized | 750,000,000 | |||||||||||||||||||||||||
Common stock, par value (in dollars per share) | $0.00 | |||||||||||||||||||||||||
Common stock, share issued | 619,741,061 | |||||||||||||||||||||||||
Share Based Compensation Arrangement By Share Based Payment Award Number Of Vested Shares (in shares) | 6,000,000 | |||||||||||||||||||||||||
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized | 580,500 | |||||||||||||||||||||||||
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized, Period For Recognition | 3 years | |||||||||||||||||||||||||
Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance | 7,000,000 | |||||||||||||||||||||||||
Shares Issued For Employee Equity Plan | 6,000,000 | |||||||||||||||||||||||||
Stock Issued During Period, Value, Share-based Compensation, Gross | 774,000 | |||||||||||||||||||||||||
Shares Issued For Employee Equity Plan Par Value (in dollars per share) | $0.13 | |||||||||||||||||||||||||
Common Stock, Capital Shares Reserved for Future Issuance | 21,250,000 | |||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | 4,500,000 | |||||||||||||||||||||||||
Common Stock, Shares, Outstanding | 612,741,061 | |||||||||||||||||||||||||
Issue One [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 500,000 | |||||||||||||||||||||||||
Shares Issued, Price Per Share | $0.03 | |||||||||||||||||||||||||
Issue Two [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 2,000,000 | |||||||||||||||||||||||||
Shares Issued, Price Per Share | $0.02 | |||||||||||||||||||||||||
Issue Three [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 500,000 | |||||||||||||||||||||||||
Shares Issued, Price Per Share | $0.02 | |||||||||||||||||||||||||
Issue Four [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 1,000,000 | |||||||||||||||||||||||||
Shares Issued, Price Per Share | $0.06 | |||||||||||||||||||||||||
Issue Five [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 500,000 | |||||||||||||||||||||||||
Shares Issued, Price Per Share | $0.07 | |||||||||||||||||||||||||
Issue [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 4,250,000 | |||||||||||||||||||||||||
Investor [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 2,037,037 | |||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $0.15 | |||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues | 6,250,000 | 43,750,000 | ||||||||||||||||||||||||
Stock Issued During Period, Value, New Issues | 500,000 | 3,500,000 | ||||||||||||||||||||||||
Investor [Member] | Warrant [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues | 14,259,259 | |||||||||||||||||||||||||
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | 0.15 | |||||||||||||||||||||||||
Consultant One [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued For Noncash Consideration (in shares) | 1,250,000 | 500,000 | 500,000 | 4,000,000 | 250,000 | |||||||||||||||||||||
Stock Issued During Period, Value, Issued For Noncash Considerations | 160,000 | 31,500 | 12,400 | 120,000 | 7,500 | |||||||||||||||||||||
Share Based Compensation Arrangement By Share Based Payment Award Number Of Vested Shares (in shares) | 200,000 | |||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | 25,200 | |||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $0.08 | |||||||||||||||||||||||||
Proceeds from Issuance of Warrants | 25,035 | |||||||||||||||||||||||||
Cancellation Of Common Stock Value | 195,000 | |||||||||||||||||||||||||
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Number | 1,200,000 | 1,000,000 | 2,750,000 | |||||||||||||||||||||||
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested In Period | 1,000,000 | 1,250,000 | ||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value | 22,700 | 37,500 | ||||||||||||||||||||||||
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non vested Value | 22,700 | 82,500 | ||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | 45,400 | |||||||||||||||||||||||||
Share Based Compensation Arrangement By Share Based Payment Award Number Of Non Vested Fair Value | 22,050 | |||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 375,000 | 500,000 | 2,000,000 | |||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues | 375,000 | |||||||||||||||||||||||||
Stock Issued During Period, Value, New Issues | 47,250 | |||||||||||||||||||||||||
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $0.13 | |||||||||||||||||||||||||
Warrants and Rights Outstanding | 36,250 | |||||||||||||||||||||||||
Shares Issued, Price Per Share | $0.13 | $0.06 | $0.13 | $0.02 | $0.03 | $0.06 | $0.03 | |||||||||||||||||||
Stock Issued During Period Issued For Non cash Considerations Par Value | $0.02 | |||||||||||||||||||||||||
Consultant One [Member] | Warrant [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Stock Issued During Period, Value, New Issues | 271,250 | |||||||||||||||||||||||||
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $0.08 | |||||||||||||||||||||||||
Fair Value Adjustment of Warrants | 271,250 | |||||||||||||||||||||||||
Consultant Two [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Share Based Compensation Arrangement By Share Based Payment Award Number Of Vested Shares (in shares) | 1,500,000 | |||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 4,250,000 | |||||||||||||||||||||||||
Shares Issued, Price Per Share | $0.03 | |||||||||||||||||||||||||
Private Placement [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Common stock, par value (in dollars per share) | $0.00 | |||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued For Noncash Consideration (in shares) | 75,000,000 | 55,875,000 | ||||||||||||||||||||||||
Stock Issued During Period, Value, Issued For Noncash Considerations | 1,117,500 | |||||||||||||||||||||||||
Maximum Number Of Common Stock Private Offering | 120,000,000 | |||||||||||||||||||||||||
Maximum Proceeds From Issuance Of Common Stock Private Offering | 1,200,000 | |||||||||||||||||||||||||
Payments of Stock Issuance Costs | 199,089 | 30,054 | ||||||||||||||||||||||||
Common Stock [Member] | ||||||||||||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||||||||||||
Share Based Compensation Arrangement By Share Based Payment Award Number Of Vested Shares (in shares) | 1,750,000 | 1,750,000 | 3,750,000 | |||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | 35,000 | 35,000 | 75,000 | |||||||||||||||||||||||
Share Based Compensation Arrangement By Share Based Payment Award Value Of Unvested Common Stock | $10,000 | $140,000 | ||||||||||||||||||||||||
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Of Unvested Common Stock | 500,000 | 7,000,000 |
Registration_Statement_on_Form1
Registration Statement on Form S-3 (Details Textual) (USD $) | 12 Months Ended | |
Dec. 31, 2014 | Mar. 31, 2015 | |
Maximum Securities Available for Offering As Per Registration Statement | $100,000,000 | |
Maximum Amount of Offering Price As Per Registration Statement | 25,000,000 | |
Percentage Of Commission On Gross Sales Price Per Share | 3.00% | |
Scenario, Forecast [Member] | ||
Outstanding Common Stock Held by Non Affiliates Aggregate Market Value | $75,000,000 |
Income_Taxes_Details
Income Taxes (Details) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
Deferred Tax Assets, Net [Abstract] | ||
NOL carryover | $1,723,014 | $1,010,992 |
Impairments | 33,931 | 33,931 |
Warrants | 498,575 | 0 |
Valuation allowance | -2,255,520 | -1,044,923 |
Net deferred tax asset | $0 | $0 |
Income_Taxes_Details_1
Income Taxes (Details 1) (USD $) | 12 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
Income Taxes Disclosure [Line Items] | ||
Book Loss | $1,059,467 | $249,600 |
State taxes | 151,130 | 35,605 |
Deductible differences | 0 | 28,832 |
Change in valuation allowance | -1,210,597 | -314,037 |
Provision for Income Taxes | $0 | $0 |
Income_Taxes_Details_Textual
Income Taxes (Details Textual) (USD $) | 12 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
Operating Loss Carryforwards [Line Items] | ||
Operating Loss Carryforwards | $4,435,042 | |
Deferred Tax Assets, Valuation Allowance | 2,255,520 | 1,044,923 |
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | $1,210,597 | $314,037 |
Loss_Per_Share_Details
Loss Per Share (Details) (USD $) | 12 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
Schedule of Earnings Per Share [Line Items] | ||
Loss from continuing Operations available to Common stockholders (numerator) | ($3,116,080) | ($734,117) |
Weighted average number of common shares Outstanding used in loss per share during the Period (denominator) (in shares) | 610,344,691 | 489,921,337 |
Furniture_and_Equipment_Detail
Furniture and Equipment (Details) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
Property, Plant and Equipment [Line Items] | ||
Property and Equipment | $924,319 | $112,371 |
Less: Accumulated Depreciation | -121,292 | -100,952 |
Net Property and Equipment | $803,027 | $11,419 |
Furniture_and_Equipment_Detail1
Furniture and Equipment (Details Textual) (USD $) | 12 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
Depreciation | $20,340 | $10,587 |
Capitalized Costs, Asset Retirement Costs | $732,028 |
Intangible_Assets_Details
Intangible Assets (Details) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
Finite-Lived Intangible Assets [Line Items] | ||
Less: Accumulated Amortization | ($269,237) | ($266,928) |
Net Intangible Assets | 95,847 | 70,494 |
Customer Contracts [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-Lived Intangible Assets, Gross | 262,009 | 262,009 |
Provisional Patent Applications [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-Lived Intangible Assets, Gross | 63,823 | 36,161 |
Utility Patents [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-Lived Intangible Assets, Gross | $39,252 | $39,252 |
Intangible_Assets_Details_1
Intangible Assets (Details 1) (USD $) | Dec. 31, 2014 |
Finite-Lived Intangible Assets [Line Items] | |
2015 | $2,309 |
2016 | 2,309 |
2017 | 2,309 |
2018 | 2,309 |
2019 | 2,309 |
Thereafter | 20,479 |
Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year | $32,024 |
Intangible_Assets_Details_Text
Intangible Assets (Details Textual) (USD $) | 12 Months Ended | ||
Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2011 | |
Finite-Lived Intangible Assets [Line Items] | |||
Finite-Lived Intangible Asset, Useful Life | 3 years | ||
Amortization of Intangible Assets | $2,309 | $89,513 | |
Impairment of Intangible Assets, Finite-lived | $0 | $87,340 |
Commitments_and_Contingencies_
Commitments and Contingencies (Details Textual) (USD $) | 12 Months Ended |
Dec. 31, 2014 | |
Loss Contingencies [Line Items] | |
Operating Leases, Rent Expense | $46,798 |
Operating Leases, Future Minimum Payments Receivable | $27,000 |
Concentrations_Details
Concentrations (Details) (Revenue [Member]) | 12 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
Customer A [Member] | ||
Concentration Risk [Line Items] | ||
Concentration Risk, Percentage | 30.00% | 22.00% |
Customer B [Member] | ||
Concentration Risk [Line Items] | ||
Concentration Risk, Percentage | 27.00% | 19.00% |
Customer C [Member] | ||
Concentration Risk [Line Items] | ||
Concentration Risk, Percentage | 21.00% | 0.00% |
Customer D [Member] | ||
Concentration Risk [Line Items] | ||
Concentration Risk, Percentage | 18.00% | 50.00% |
Concentrations_Details_1
Concentrations (Details 1) (Accounts Receivable [Member]) | 12 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
Customer A [Member] | ||
Concentration Risk [Line Items] | ||
Concentration Risk, Percentage | 16.00% | 19.00% |
Customer B [Member] | ||
Concentration Risk [Line Items] | ||
Concentration Risk, Percentage | 50.00% | 31.00% |
Customer C [Member] | ||
Concentration Risk [Line Items] | ||
Concentration Risk, Percentage | 13.00% | 0.00% |
Customer D [Member] | ||
Concentration Risk [Line Items] | ||
Concentration Risk, Percentage | 0.00% | 39.00% |
Customer E [Member] | ||
Concentration Risk [Line Items] | ||
Concentration Risk, Percentage | 20.00% | 4.00% |
Subsequent_Events_Details_Text
Subsequent Events (Details Textual) | 1 Months Ended | ||
Nov. 30, 2014 | 31-May-14 | Mar. 31, 2015 | |
Subsequent Event [Line Items] | |||
Stock Issued During Period, Shares, New Issues | 1,500,000 | 2,187,500 | |
Director [Member] | |||
Subsequent Event [Line Items] | |||
Stock Issued During Period, Shares, New Issues | 1,500,000 | ||
Subsequent Event [Member] | Equity Incentive Plan 2013 [Member] | Director [Member] | |||
Subsequent Event [Line Items] | |||
Stock Issued During Period, Shares, New Issues | 1,000,000 | ||
Subsequent Event [Member] | Equity Incentive Plan 2013 [Member] | Officer and two consultants [Member] | |||
Subsequent Event [Line Items] | |||
Stock Issued During Period, Shares, New Issues | 2,603,774 |